Angela V. Hafner, Associate Director, External Innovation at Agenus, made the following post on LinkedIn:
“Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program”
For details click here.
Source: Angela V. Hafner/LinkedIn